BioProtect Overview
- Year Founded
-
2004
- Status
-
Private
- Employees
-
84
- Latest Deal Type
-
2ndary - Private
- Investors
-
21
BioProtect General Information
Description
Developer of a pro-space balloon system designed to safely and temporarily separate the rectum during prostate cancer radiation therapy. The company's system acts as a spacer for the protection of healthy tissues in patients receiving radiotherapy for prostate cancer, enabling healthcare institutions to decrease the probability of serious and chronic radiation side effects while improving biochemical tumor control.
Contact Information
Website
www.bioprotect.comCorporate Office
- 8 Tsor Street
- Tzur Yigal 4486200
- Israel
Corporate Office
- 8 Tsor Street
- Tzur Yigal 4486200
- Israel
BioProtect Timeline
BioProtect Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 15. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 14. Later Stage VC | 27-Sep-2023 | Completed | Generating Revenue | |||
| 13. Grant | 02-Mar-2023 | Completed | Generating Revenue | |||
| 12. Debt - General | 01-Dec-2022 | Completed | Generating Revenue | |||
| 11. Later Stage VC (Series D) | 21-Sep-2020 | Completed | Generating Revenue | |||
| 10. Accelerator/Incubator | 01-Jan-2018 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series C) | 13-Apr-2017 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series B) | 01-Jun-2016 | Completed | Generating Revenue | |||
| 7. Grant | 01-Oct-2014 | $8K | $8.66M | Completed | Generating Revenue | |
| 6. Angel (individual) | 15-Nov-2013 | $3.92M | $8.66M | Completed | Generating Revenue |
BioProtect Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Preferred C2 | ||||||||
| Preferred C1 | ||||||||
| Preferred B | ||||||||
| Preferred A4 | ||||||||
| Preferred A3 | ||||||||
| Preferred A2 | ||||||||
| Preferred A1 | 2,838 | $350 | $350 | 1x | $350 | 0.18% | ||
| Preferred A | 4,500 | $141.52 | $141.52 | 1x | $141.52 | 0.26% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BioProtect Comparisons
Industry
Financing
Details
BioProtect Competitors (2)
One of BioProtect’s 2 competitors is IlluminOss, a Private Equity-Backed company based in East Providence, RI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| IlluminOss | Private Equity-Backed | East Providence, RI | ||||
| Boston Scientific | Corporation | Marlborough, MA |
BioProtect Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BioProtect Patents
BioProtect Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4489700-A2 | Apparatus and method for protecting biological tissue during cryotherapy | Pending | 13-May-2022 | ||
| EP-4468935-A1 | Medical dilator with echogenetic marker | Pending | 25-Jan-2022 | ||
| US-20250098954-A1 | Medical dilator with echogenetic marker | Pending | 25-Jan-2022 | ||
| EP-4468935-A4 | Medical dilator with echogenetic marker | Pending | 25-Jan-2022 | ||
| EP-2521586-A2 | Controlled tissue dissection systems and methods | Inactive | 07-Jan-2010 | A61B8/12 |
BioProtect Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BioProtect Investors (21)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| MVM Partners | Growth/Expansion | Minority | ||
| European Innovation Council | Venture Capital | Minority | ||
| Horizon Europe | Other | |||
| Almeda Ventures | Venture Capital | Minority | ||
| Consensus Business Group | Asset Manager | Minority |
BioProtect FAQs
-
When was BioProtect founded?
BioProtect was founded in 2004.
-
Where is BioProtect headquartered?
BioProtect is headquartered in Tzur Yigal, Israel.
-
What is the size of BioProtect?
BioProtect has 84 total employees.
-
What industry is BioProtect in?
BioProtect’s primary industry is Surgical Devices.
-
Is BioProtect a private or public company?
BioProtect is a Private company.
-
What is BioProtect’s current revenue?
The current revenue for BioProtect is .
-
How much funding has BioProtect raised over time?
BioProtect has raised $65.8M.
-
Who are BioProtect’s investors?
MVM Partners, European Innovation Council, Horizon Europe, Almeda Ventures, and Consensus Business Group are 5 of 21 investors who have invested in BioProtect.
-
Who are BioProtect’s competitors?
IlluminOss and Boston Scientific are competitors of BioProtect.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
